Brief: Nanologica Q1 Operating Loss Widens To 15.6 Mln
29/04/2022 11:08
April 29 (Reuters) - Nanologica AB (publ) NICA.ST :
* Q1 NET SALES TSEK 270 (5,622)
* Q1 OPERATING PROFIT TSEK -15 592 VERSUS LOSS TSEK 6 768
* WE ARE SEEING A LOT OF ACTIVITY IN PEPTIDE DRUG
DEVELOPMENT AND
EXPERIENCED A LOT OF INTEREST IN OUR PRODUCTS
* IN LIGHT OF THIS, WE STAND BY OUR VIEW THAT IT IS
REASONABLE TO
ACHIEVE SALES IN CHROMATOGRAPHY OF SEK 100 - 300 MILLION BY 2024
Further company coverage: NICA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))